Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study).
Aguilar-Salinas CA, Assis-Luores-Vale A, Stockins B, Rengifo HM, Dondici Filho J, Afiune Neto A, Rabelo LM, Torres KP, Oliveira JE, Machado CA, Reyes E, Saavedra V, Florenzano F, Hernández MV, Hernandez Jiménez S, Ramírez E, Vazquez C, Salinas S, Hernández I, Medel O, Moreno R, Lugo P, Alvarado R, Mehta R, Gutierrez V, Gómez Pérez FJ.
Aguilar-Salinas CA, et al. Among authors: medel o.
Cardiovasc Diabetol. 2004 Jul 23;3:8. doi: 10.1186/1475-2840-3-8.
Cardiovasc Diabetol. 2004.
PMID: 15272932
Free PMC article.